The European Medicines Agency's committee has recommended approval of French drugmaker Sanofi's first-of-its-kind drug that ...

New research reveals metformin may reduce exercise benefits for diabetes patients, affecting blood sugar control and fitness ...

The results of a late-stage drug trial released Thursday are raising hopes that type 1 diabetes patients with chronic kidney ...

The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe acute pain. The drug, called Journavx (suzetrigine) ...

Millions in India face chronic kidney disease, with drug-induced damage a significant concern. Common medications like NSAIDs ...

(CNN) — The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades. The drug, suzetrigine, is a 50-milligram prescription ...

Nitazenes, a class of synthetic drugs 40 times more potent than fentanyl, are steadily becoming more common on both sides of ...

Among adults with type 2 diabetes who started noninsulin second-line therapy, most modified treatment within 1 year. Discontinuation was by far the most common modification. Objectives: To describe ...

Most newly treated patients with type 2 diabetes exhibit suboptimal medication persistence, which is associated with higher risk of hospitalization and increased medical costs. Objectives: Medication ...

(CNN) -- The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades. (CNN) — The US Food and Drug Administration signed off ...